This inventor holds 28 USPTO granted patents and 1 published patent application, primarily in Therapeutic Agents. Top assignees: Imperial Chemical Industries Limited, Zeneca Limited, Imperial Chemical House. Active years: 1981-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
14 out of 3,840 
13 out of 854 
2 out of 2 Years Active: 1981-1999
Areas of Expertise:
Title: **Cyrus J. Ohnmacht: An Innovator in Pharmaceutical Patents**
Introduction
Cyrus J. Ohnmacht, based in Wilmington, DE, is a prominent inventor with an impressive portfolio of 28 patents. His work focuses primarily on pharmaceutical innovations, specifically in the realm of compounds beneficial for treating various medical conditions such as asthma and urinary incontinence. His contributions to the field have significantly advanced the development of effective therapies.
Latest Patents
Among Cyrus J. Ohnmacht's latest innovations are patents for cyclic amide derivatives aimed at treating asthma. These compounds, defined by formula I, represent nonpeptide antagonists of neurokinin A, proving useful in the management of asthma symptoms. The patents also encompass the disclosures of pharmaceutical compositions, processes for preparing the compounds, and their intermediates. Furthermore, he has developed therapeutic compounds that target urinary incontinence, showcasing a deep understanding of the pharmaceutical industry and the needs of patients.
Career Highlights
Cyrus has made substantial contributions in the field while working with industry leaders such as Imperial Chemical Industries Limited and Zeneca Limited. These experiences have equipped him with the skills and knowledge necessary to navigate complex scientific challenges and drive innovation within the pharmaceutical sector.
Collaborations
Throughout his career, Cyrus J. Ohnmacht has collaborated with notable colleagues, including Diane A. Trainor and Keith Russell. These partnerships emphasize the collaborative nature of scientific research and innovation, leading to the successful development of groundbreaking therapeutic solutions.
Conclusion
Cyrus J. Ohnmacht has established himself as a key figure in pharmaceutical innovation through his numerous patents and collaborative efforts. His work continues to influence the industry, paving the way for advancements in treatment options for common yet impactful health issues such as asthma and urinary incontinence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile